We are live on ! Find out more
WEC

Winslow Evans & Crocker Portfolio holdings

AUM $528M
1-Year Est. Return 30.99%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+30.99%
3 Year Est. Return
+76.2%
5 Year Est. Return
+147.26%
10 Year Est. Return
AUM
$365M
AUM Growth
+$46.1M
Cap. Flow
+$37.6M
Cap. Flow %
10.3%
Top 10 Hldgs %
19.35%
Holding
1,326
New
84
Increased
304
Reduced
473
Closed
56

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
ORCL icon
Oracle
ORCL
+$1.05M
3
ETP
Energy Transfer Partners L.p.
ETP
+$657K
4
HDB icon
HDFC Bank
HDB
+$522K
5
BA icon
Boeing
BA
+$473K

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Healthcare 11.88%
3 Financials 10.98%
4 Consumer Discretionary 8.56%
5 Energy 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDC icon
51
Western Digital
WDC
$179B
$1.72M 0.47%
25,743
+6,911
+37% +$459K
WPC icon
52
W.P. Carey
WPC
$17.1B
$1.67M 0.46%
25,948
+3,768
+17% +$238K
PG icon
53
Procter & Gamble
PG
$343B
$1.67M 0.46%
19,133
-233
-1% -$20.5K
KO icon
54
Coca-Cola
KO
$354B
$1.54M 0.42%
34,626
+14,056
+68% +$621K
EMLP icon
55
First Trust North American Energy Infrastructure Fund
EMLP
$4.18B
$1.52M 0.42%
62,006
-688
-1% -$17.2K
PNC icon
56
PNC Financial Services
PNC
$100B
$1.45M 0.4%
11,598
-270
-2% -$32.6K
V icon
57
Visa
V
$677B
$1.44M 0.4%
15,530
+10,334
+199% +$959K
CERN
58
DELISTED
Cerner Corp
CERN
$1.43M 0.39%
22,137
+9,209
+71% +$588K
TRMB icon
59
Trimble
TRMB
$12.3B
$1.43M 0.39%
40,235
-751
-2% -$26.1K
ABT icon
60
Abbott
ABT
$180B
$1.4M 0.38%
28,976
+2,616
+10% +$118K
FDL icon
61
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.72B
$1.4M 0.38%
49,628
-908
-2% -$25.9K
CVS icon
62
CVS Health
CVS
$137B
$1.36M 0.37%
16,964
+7,408
+78% +$585K
STT icon
63
State Street
STT
$50.9B
$1.35M 0.37%
15,064
-2
-0% -$166
BMY icon
64
Bristol-Myers Squibb
BMY
$127B
$1.35M 0.37%
24,304
+5,324
+28% +$290K
NVDA icon
65
NVIDIA
NVDA
$5.01T
$1.32M 0.36%
377,200
+162,560
+76% +$516K
UNP icon
66
Union Pacific
UNP
$183B
$1.3M 0.36%
12,012
+3,026
+34% +$330K
EMR icon
67
Emerson Electric
EMR
$82.9B
$1.28M 0.35%
21,488
+7,800
+57% +$462K
CSCO icon
68
Cisco
CSCO
$450B
$1.26M 0.35%
40,313
+4,559
+13% +$149K
ADBE icon
69
Adobe
ADBE
$89.5B
$1.26M 0.34%
9,034
+6,992
+342% +$957K
CELG
70
DELISTED
Celgene Corp
CELG
$1.25M 0.34%
9,597
+1,117
+13% +$137K
ROK icon
71
Rockwell Automation
ROK
$51.4B
$1.24M 0.34%
7,714
+3,702
+92% +$584K
EFX icon
72
Equifax
EFX
$20.3B
$1.23M 0.34%
8,916
+116
+1% +$15.9K
GLD icon
73
SPDR Gold Trust
GLD
$131B
$1.22M 0.33%
10,342
-1,494
-13% -$179K
AGN
74
DELISTED
Allergan plc
AGN
$1.21M 0.33%
4,988
-14,646
-75% -$3.44M
UN
75
DELISTED
Unilever NV New York Registry Shares
UN
$1.21M 0.33%
21,833
-207
-0.9% -$11.2K

Similar funds

Winslow Evans & Crocker's Q2 2017 Portfolio in Review

As of Q2 2017, Winslow Evans & Crocker held 1,326 positions worth $365M, up 14% from $318M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Winslow Evans & Crocker deployed $37.6M of net new capital in Q2 2017, opening 84 new positions and adding to 304 existing holdings. Its largest new stake was Idexx Laboratories: 3,900 shares worth $629K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Allergan plc, an estimated $3.44M trimmed.

  • Winslow Evans & Crocker's largest Q2 2017 buy was Idexx Laboratories: 3,900 shares worth $629K.
  • Winslow Evans & Crocker added most to Microsoft in Q2 2017, an estimated $3.28M increase.
  • Winslow Evans & Crocker's biggest Q2 2017 reduction was Allergan plc, cutting an estimated $3.44M.
  • Winslow Evans & Crocker fully exited State Street Energy Select Sector SPDR ETF in Q2 2017, selling an estimated $428K.
  • Winslow Evans & Crocker's ten largest holdings make up 19% of its $365M portfolio in Q2 2017.
  • Winslow Evans & Crocker opened 84 new positions and closed 56 in Q2 2017.
  • Winslow Evans & Crocker's portfolio value rose 14% quarter-over-quarter to $365M.

Based on Winslow Evans & Crocker's 13F filing for Q2 2017, filed 14 Jul 2017.